Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1986Journal of Clinical Oncology

Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.

View Full Paper
Ask AI
Bookmark
Share

Authors

EMEnrica MorraIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"MLMario LazzarinoUniversity of MilanDID InverardiAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morra et al. (1986) studied this question.

synapsesocial.com/papers/6a1f6d8cd03d2b72e7236a12https://doi.org/10.1200/jco.1986.4.8.1207
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-dose cytosine arabinoside in non-Hodgkin's lymphoma.1983 · 77 citations
  2. 2Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.1983 · 125 citations
  3. 3High-dose cytosine arabinoside therapy for refractory leukemia1983 · 370 citations
  4. 4Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)1982 · 81 citations
  5. 5Remission induction of meningeal leukemia with high-dose intravenous methotrexate.1985 · 102 citations